Ditchcarbon
  • Contact
  1. Organizations
  2. Glaukos
Public Profile
Health Services
US
updated 2 months ago

Glaukos Sustainability Profile

Company website

Glaukos Corporation, a pioneering force in the ophthalmic industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 1998, Glaukos has established itself as a leader in developing innovative therapies for glaucoma and other eye diseases. The company is renowned for its unique micro-invasive surgical procedures, particularly the iStent® technology, which has transformed the treatment landscape for patients suffering from glaucoma. With a commitment to advancing eye care, Glaukos has achieved notable milestones, including the first FDA approval of a micro-invasive glaucoma surgery device. The company’s dedication to research and development has positioned it at the forefront of the ophthalmic market, making significant contributions to improving patient outcomes and enhancing the quality of life for those affected by vision-related conditions.

DitchCarbon Score

How does Glaukos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Glaukos's score of 33 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.

60%

Let us know if this data was useful to you

Glaukos's reported carbon emissions

In 2024, Glaukos Corporation reported total carbon emissions of approximately 3,058,600 kg CO2e, comprising 523,300 kg CO2e from Scope 1 and 2,535,300 kg CO2e from Scope 2 emissions. This marks an increase from 2023, where total emissions were about 2,734,800 kg CO2e, with Scope 1 emissions at 575,400 kg CO2e and Scope 2 emissions at 2,159,400 kg CO2e. In 2022, emissions were significantly lower at approximately 1,929,600 kg CO2e, with Scope 1 at 569,400 kg CO2e and Scope 2 at 1,360,200 kg CO2e. Glaukos has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 emissions to near zero by the middle of this decade, specifically targeting the years 2023 to 2025. This commitment reflects a proactive approach to climate action, aligning with industry standards for sustainability and emissions reduction. The company does not currently report Scope 3 emissions, indicating a potential area for future focus. All emissions data is sourced directly from Glaukos Corporation, with no cascaded data from parent or related organisations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
569,400
000,000
000,000
Scope 2
1,360,200
0,000,000
0,000,000
Scope 3
-
-
-

How Carbon Intensive is Glaukos's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Glaukos's primary industry is Health Services, which is low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Glaukos's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Glaukos is in US, which has a low grid carbon intensity relative to other regions.

Glaukos's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Glaukos has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Glaukos's Emissions with Industry Peers

Peschke Trade GmbH

CH
Updated about 7 hours ago

EYP

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Phonak GmbH

DE
•
Health and social work services (85)
Updated 1 day ago

Lumenis Be Ltd.

IL
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

IRIDEX Corporation

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Aerie Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy